Rodríguez-García María Elena, Martín-Hernández Elena, de Aragón Ana Martínez, García-Silva María Teresa, Quijada-Fraile Pilar, Arenas Joaquín, Martín Miguel A, Martínez-Azorín Francisco
Laboratorio de Enfermedades Mitocondriales, Instituto de Investigación Hospital 12 de Octubre (i+12), Centro de Actividades Ambulatorias (CAA), 6ª Planta, Bloque E, Avda. Córdoba s/n, E-28041, Madrid, Spain.
Unidad Pediátrica de Enfermedades Raras, Enfermedades Mitocondriales y Metabólicas Hereditarias, Hospital 12 de Octubre, E-28041, Madrid, Spain.
Neurogenetics. 2016 Jan;17(1):51-6. doi: 10.1007/s10048-015-0463-z. Epub 2015 Oct 7.
We report the clinical and genetic findings in a Spanish boy who presented MEGDEL syndrome, a very rare inborn error of metabolism. Whole-exome sequencing uncovered a new homozygous mutation in the serine active site containing 1 (SERAC1) gene, which is essential for both mitochondrial function and intracellular cholesterol trafficking. Functional studies in patient fibroblasts showed that p.D224G mutation affects the intracellular cholesterol trafficking. Only three missense mutations in this gene have been described before, being p.D224G the first missense mutation outside of the SERAC1 serine-lipase domain. Therefore, we conclude that the defect in cholesterol trafficking is not limited to alterations in this specific part of the protein.
我们报告了一名患有MEGDEL综合征(一种非常罕见的先天性代谢缺陷病)的西班牙男孩的临床和基因研究结果。全外显子组测序发现丝氨酸活性位点包含蛋白1(SERAC1)基因存在一个新的纯合突变,该基因对于线粒体功能和细胞内胆固醇转运均至关重要。对患者成纤维细胞的功能研究表明,p.D224G突变影响细胞内胆固醇转运。此前仅报道过该基因的三个错义突变,p.D224G是SERAC1丝氨酸脂肪酶结构域外的首个错义突变。因此,我们得出结论,胆固醇转运缺陷并不局限于该蛋白这一特定部位的改变。